Abstract C-reactive protein (CRP) is widely used in early detection of sepsis or organ dysfunction. Several single nucleotide polymorphisms (SNPs) in the CRP gene are shown to be associated with variability of basal CRP. To clarify the effect of these SNPs to CRP response in systemic infections, we compared genetic and clinical data on patients with Staphylococcus aureus bacteremia (SAB). Six SNPs in the CRP gene region (rs2794521, rs30912449, rs1800947, rs1130864, rs1205 and rs3093075) were genotyped in 145 patients and analyzed for associations with CRP and various clinical outcomes. We found that the rare minor A-allele of triallelic SNP rs30912449 (C > T > A) and presence of a deep infection focus were strongly associated to the higher maximal CRP during the first week of SAB. Median of the maximal CRP in patients who had the A-minor allele was 282 mg/L (interquartile range [IQR, defined as the difference between the third quartile and the first quartile], 169 mg/L) but only 179 mg/L (IQR, 148 mg/L) in patients without this allele (P=0.004), and CRP in patients who had deep infection focus was higher 208 mg/L (IQR, 147 mg/L) than in other patients 114 mg/L (IQR, 121 mg/l) (P<0.0001).
Introduction
C-reactive protein (CRP) is rapidly synthesized in liver as a part of acute phase response following infection, injury or trauma [1] . In clinical practice, rising CRP has been found useful in detection of sepsis or organ dysfunction [2] . Changes in CRP levels have been used to monitor the treatment response, whereas the decline of CRP level is one of the earliest markers of improved condition [3] . Although CRP seems to be a good marker of systemic inflammation and a valuable clinical tool in severe infections [4] , its exact role in defence against microbes remains incompletely understood [5] .
Based on family and twin studies, it is estimated that genetic factors account for 35-40% of the variance of the changes in basal CRP levels [6] [7] [8] . The CRP gene is located on chromosome 1q32 and it consists of 2 exons and 1 intron [9, 10] . Several SNPs in the CRP gene are shown to be associated with basal CRP level variability [11] . Moreover, in the Women's Genome Health Study seven genetic loci were shown to be associated with circulating CRP levels in a genome-wide setting, including the CRP locus and six other loci with a trans-effect [12] . Some SNPs in the CRP gene might also be associated with an increased risk for ischemic stroke [13] , for reduced arterial compliance [14] , or even for risk of getting type 2 diabetes
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The online version of this article (doi:10.1007/s10096-010-0978-z) contains supplementary material, which is available to authorized users. mellitus [15] . However, the causative effect of the cisacting SNPs on ischemic heart disease remains under some controversy [16] . CRP gene SNPs have been related to susceptibility or worse outcome in some infections as well as other diseases. A CRP gene poly (GT) allele was associated with susceptibility to invasive pneumococcal disease [17] and CRP gene promoter region polymorphism rs2794521 with an increased mortality to invasive pneumococcal disease [18] . However, little is known about how the polymorphism affects CRP levels stimulated by infection or trauma. Recently, lower CRP levels after coronary by-pass operation have been shown to be associated with minor allele of the synonymous coding SNP rs1800947 within exon 2 in the CRP gene [19] . This data indicates that polymorphisms in the CRP gene might be an important factor in CRP response in severe systemic infections. However, the effect of these variations on CRP levels in severe infections has not been evaluated.
S. aureus is the second most common bloodstream isolate in all age groups and it still carries high overall mortality up to 39% [20] [21] [22] . In practice, the clinical course of S. aureus bacteremia (SAB) is determined by its complications, particularly by the development of deep infections and thromboembolic events [23] [24] [25] . The reported frequency of deep infection foci in SAB varies greatly, but in a recent trial it was over 80% [26] . Therefore, SAB could be a suitable infection to study the possible effect of genetic polymorphisms to frequency of complications and CRP response. To assess the possible contribution of variations in the CRP gene to complications in SAB we genotyped six SNPs in the CRP gene and analyzed their possible correlation to CRP levels and to various clinical outcome parameters.
Methods

Patient population
A total of 430 patients with blood culture positive for S. aureus were enrolled consecutively in five university hospitals and in seven tertiary care hospitals in Finland between January and May 1999, and between January 2000 and August 2002. The trial aimed primarily to examine the potential of two fluoroquinolones (trovafloxacin and levofloxacin) to reduce the high mortality and complication rates in SAB, when added to the standard treatment [26] . The exclusion criteria were: age younger than 18 years, imprisonment, proven or suspected pregnancy, breastfeeding, epilepsy, another bacteremia during the previous 28 days, polymicrobial bacteremia (≥3 microbes), history of allergy to any quinolone antibiotic, previous tendinitis during a fluoroquinolone therapy, prior fluoroquinolone use for more than 5 days before randomization, positive culture for S. aureus only from a central intravenous catheter, meningitis, neutropenia (<0.5×10 9 cells/L) or failure to supply an informed consent. Patients with bacteremia due to methicillin-resistant S. aureus (MRSA) and a S. aureus strain resistant to any fluoroquinolone were also excluded [26] . Each patient was recruited into the study only once to avoid double inclusion in repeated bacteremia. The protocol was approved by the ethics committees of all study sites. Written informed consent was obtained from all patients or their representatives. Permission for genetic blood samples was asked for patients only from Helsinki University Central Hospital. Thus, the genetic blood samples were obtained from 151 of 158 patients from this study site. Blood samples from three patients could not be obtained for further analysis and three subjects were discarded due to technical problems with insufficient DNA yield. In total, 145 patients were included in this study from Helsinki University Central Hospital.
Definitions
Intravenous drug users (IDUs) were defined as patients who had injected drugs within the past 6 months before randomization based on a history taken on admission. SAB was hospital-acquired if the first positive blood culture was obtained ≥48 hours after admission or the patient was a resident in a long-term care facility or had attended haemodialysis within the preceding 2 months. Prognosis or severity of underlying diseases were characterized as healthy, nonfatal, ultimately or rapidly fatal disease according to the criteria of McCabe and Jackson [27] . Infection focus was documented by clinical, bacteriological, radiological, or pathological investigations. Intravenous catheter-associated bacteremia was defined using the guidelines of the Infectious Disease Society of America [28] . Deep infection focus was classified as endocarditis, pneumonia, deep-seated abscess, osteomyelitis, septic arthritis, meningitis, septic thrombophlebitis, mediastinitis, urinary tract infection, infection of a prosthetic device, or recurrent SAB as described in our previously published article [29] . Time to defervescence was recorded in days until axillary temperature was <37.5°C.
Serum CRP and leukocyte measurements
Blood samples for CRP measurement and leukocyte count were conducted on the day of positive blood culture for S. aureus, at randomization and every other day during the first week. Serum concentrations of CRP and leukocyte count were measured in the study site laboratory by standard laboratory methods. The serum or plasma (use of plasma instead of serum began 18.3.2002) was subjected to automatic immunoturbidimetric analysis using analyzers 917 or Modular PP-analyzer (Hitachi Ltd, Tokyo, Japan) and Tina-quant CRP reagents (Roche Diagnostics, Tina-quant CRP). The normal value of CRP concentration was <10 mg/L for both methods. Leukocytosis was determined if white blood cell count was over 12×10 9 cells/L.
DNA sequencing and genotyping DNA was extracted using the phenol chloroform extraction method. DNA quantity was measured by absorbance at 260 nm and by Pico Green fluorescence assay (PicoGreen dsDNA Quantitation Kit, Molecular Probes, Carlsbad, USA). The detection of SNPs was performed by the analysis of primer extension products from amplified genomic DNA using Sequenom MassArray system with the homogeneous Mass Extension (hME) reaction (Sequenom, San Diego, USA). PCR and extension reactions were designed using MassARRAY design software and were carried out using 10 ng of template DNA. with the outcome were then included in the multivariate regression in order of strength of their correlation with the outcome variable. When a new explanatory variable was shown to contribute to the variance, influence on the variables already in the model and possible collinearity with them was assessed. All tests were 2-tailed and P<0.05 was considered significant. For the multiple comparisons, the FDR estimation method was applied to association analyses [30] .
Results
In total, 145 patients with SAB were included in this study. A majority of the patients were male (66%) and their mean age was 52 years (Table 1) . A deep infection focus was found in 124 (86%) patients within the 3-month study period.
The genotype distributions of CRP gene SNPs did not deviate from the Hardy-Weinberg equilibrium (supplementary material). Among the six selected haplotype bin tagging SNPs, two are located in the promoter region rs2794521 and rs3091244, one is located in exon 2 rs1800947, one in 3Ú TR region rs1130864, and two in 3′ flanking region rs1205 and rs3093075. All these SNPs were found to be in strong linkage disequilibrium (LD) by Haploview 3.2 program [31] . In particular, rs3091244 A-minor allele is in full LD with rs3093075 and rs3091244 T-minor allele with rs1130864. All CRP gene SNPs except rs1205 are within one haplotype block.
When SNPs of the CRP gene were analyzed in additive and recessive genetic models they were found not to affect the CRP levels at the time of S. aureus positive blood culture or 7 days after it. However, the maximal CRP levels [27] during the first week of illness were significantly elevated in patients who had either A-minor allele of rs3091244 or T-minor allele of rs3093075 when compared to patients without minor alleles of these SNPs (Table 2 ). Due to strong LD between these two SNPs, the results reflect the same signal. No differences were observed in occurrence of predisposing factors, underlying diseases and clinical manifestations or number of patients with a deep infection focus in patients with one copy of minor allele A of rs3091244 when compared to patients without this minor allele (Table 3) . Presence of a deep infection focus and rs3091244 A-minor allele carriage were both found to be significantly associated with maximal CRP level during the first week, and this effect persisted in multivariate analysis (Table 4) . Associations were retained even after the multiple comparisons with FDR estimation using an FDR threshold <0.10 ( Table 4 ). The median of the maximal CRP level in patients who had a deep infection focus was 208 mg/L (IQR, 147 mg/L) but only 114 mg/L (IQR, 121 mg/l) in patients without it (P<0.0001). Other possible influencing factors such as age, sex, BMI, surgical intervention or intravenous drug abuse were not found to be significant determinants of the maximal CRP level (Table 4) .
Associations between any other parameter and SNPs were not detected when data was analyzed in additive and recessive models. The degree of leukocytosis, time to defervescence, number of any deep infection foci during the first week or three months, the number of patients who had intravenous-catheter-associated bacteremia, or who died within 28 days or three months were not influenced by polymorphisms.
Discussion
To our knowledge, this is the first study to investigate the association between CRP gene SNPs and CRP levels in the acute phase of SAB. Polymorphisms in the CRP locus are shown to have strong influence on low basal CRP levels [11] but reports on the effect of these SNPs on high CRP values during systemic infections are few. We assessed the genotypes of six SNPs in the CRP gene in 145 clinically evaluated SAB patients. We demonstrated that SNP rs3091244 in the promoter region of the CRP gene was clearly associated with higher maximal CRP elevation during the first week of illness. This gene region is important in the transcriptional activity of the CRP gene [32] . Patients who were rare minor A-allele carriers of SNP rs3091244 had significantly higher maximal CRP levels as compared to patients who were not. This genetic variant, however, did not have an effect on initial CRP level measured on the day of S. aureus positive blood culture or the subsequent decline of CRP level during the treatment, neither did it affect the outcome of the disease as measured by mortality, number of deep infections or time to defervescence.
We observed significantly higher maximal CRP levels among the patients who had deep infection focus during the first week of SAB as compared to those who did not. We were not able to find this result in previous literature. However, the importance of deep infection foci on the prognosis has been shown [23] [24] [25] . Surgical procedures or even placement of a central venous catheter (CVI) might increase CRP levels but this was not observed in our study (17) 15 (14) 17 (15) population. In univariate analysis surgical interventions were not associated with elevated CRP levels and only one of the patients had CVIs placed during the first week. Our study population was a subgroup of patients in a larger study on S. aureus bacteremia which might have an effect on the results. However, the demographic factors and underlying diseases did not differ between our patient group and the original larger patient population [26] . Inadequate antibiotic treatment during the first week did not affect the results as all patients received microbiologically verified effective treatment already from the blood culture day [26] . As a limitation of the study, data on duration of symptoms prior to the onset of therapy are not available and were not analysed. Infections due to various S. aureus bacterial strains might have different effects on the CRP production although no data on this exists. The effect of variations in S. aureus strains in our results seems, however, not likely as the strains were highly variable [33] .
In contrast to our results, SNP rs2794521 in the promoter region of the CRP gene has been reported to be associated with higher mortality in bacteremia due to Streptococcus pneumoniae [18] . We could not observe that this SNP would have an impact on outcome or CRP levels in SAB. Whether this relationship to mortality counts only for S. pneumoniae or is due to other confounding factors remains to be elucidated. It has to be notified that no relationship of polymorphisms in the CRP gene and mortality was observed in the same study in bacteremia due to other microbes, namely, α-hemolytic streptococci or Escherichia coli [18] . The minor allele of SNP rs1800947 in the CRP gene was recently shown to be associated with significantly lower CRP levels in patients recovering from coronary by-pass surgery [19] . In our study, this same genotype did not seem to have any effect on CRP levels but the relatively small patient population might not make it possible to observe such an effect in our study. Other studies on CRP gene polymorphism in severe acute infections are not available.
Interestingly, this same triallelic SNP rs3091244, which we found to be associated with maximal CRP levels in SAB, has been related to high basal CRP levels as well [32, [34] [35] [36] . Although reduction of CRP levels has been shown to be clinically beneficial and is associated with positive cardiovascular outcomes [37] , associations of polymorphisms in the CRP gene with development of chronic diseases like type 2 diabetes [15, 38] or ischemic heart disease remain under some controversy.
In our study, previously reported associations of CRP gene SNPs on the unexpectedly low levels of CRP could not be seen which might be due to rather small sample size in our study. However, this might also be due to healing of infection having a greater impact on the decline of CRP as compared to genetic variability. This further suggests that in studies concerning impact of CRP gene SNPs on basal CRP level, individuals with any infections should be carefully excluded from the patient population.
To answer the question whether our finding is specific for a CRP response in SAB requires further investigation. However, already at this time one can draw certain conclusions. Our study can help to understand why individuals have such different maximal responses in CRP levels under seemingly similar conditions in bacteremia and why exceptionally high CRP does not necessarily predict the clinical course of SAB. Polymorphisms were not associated with CRP levels in the beginning of SAB. These levels have more variable factors than maximal CRP. CRP measurements started when positive blood culture was achieved, and the period of time from the onset of symptoms and first blood sampling varied between patients. This may have influenced our results. Polymorphisms did not seem to have an effect on the decline of CRP levels and this encourages continued use of CRP measurement as a clinical tool in individual surveillance of recovery.
In conclusion, our study is a reminder to interpret exceptionally high CRP values with caution and to avoid comparing them between patients. The results of this study suggest that disease severity as assessed by occurrence of a deep infection focus and genetic variability in the CRP gene might be the factors that determine the maximal CRP level in SAB. The same polymorphism that was associated with high basal CRP levels was found to be related to significantly higher maximal CRP concentrations in SAB.
